Liver perfusion and hepatocellular inflammatory response in sepsis

Acta Clinica Belgica

Volumn 54, Issue 4, 1999, Pages 201-206

  Smets, D ^a   Spapen, Herbert ^a   Diltoer, M ^a   Nguyen, D N ^a   Hubloue, I ^a   Huyghens, L ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Endotoxin; Liver; Nitric oxide; Sepsis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CATECHOLAMINE; CELL ADHESION MOLECULE; COMPLEMENT; CYTOKINE; DOBUTAMINE; ENDOTHELIN; INTEGRIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN D2; PROSTAGLANDIN E2; SELECTIN; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; HEART OUTPUT; HUMAN; KUPFFER CELL; LIVER BLOOD FLOW; LIVER DYSFUNCTION; LIVER PERFUSION; LIVER SINUSOID; NEUTROPHIL; NONHUMAN; NUTRITIONAL SUPPORT; OXYGENATION; PORTAL VEIN BLOOD FLOW; SEPSIS; SPLANCHNIC BLOOD FLOW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TONOMETRY; VASCULAR ENDOTHELIUM;

EID: 0032873913     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1999.11754232     Document Type: Article

References (49)

1. Matuschak GM. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin Chest Med. 1996; 17: 83-98.
2. Schwartz DB, Bone RC, Balk RA, Szidon JP. Hepatic dysfunction in the adult respiratory distress syndrome. Chest. 1989; 95: 871-5.
3. Parks DA, Jacobson ED. Physiology of the splanchnic circulation. Arch Intern Med. 1985; 145: 1278-81.
4. Lautt W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: Hepatic arterial buffer response. Am J Physiol. 1985; 249: G549-56.
5. Pastor CM, Billiar TR, Losser M-R, Payen DM. Liver injury during sepsis. J Crit Care. 1995; 10: 183-97.
6. Navaratnam RL, Morris SE, Traber DL, et al. Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). J Trauma. 1990; 30: 1104-15.
7. Ayuse T, Brienza N, Revelly JP, O'Donnell CP, Boitnott JK, Robotham JL. Alterations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol. 1995; 268: H1106-14.
8. Brinkmann A, Calzia E, Träger K, Radermacher P. Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance. Intensive Care Med. 1998; 24: 542-56.
9. Maynard ND, Bihari DJ, Dalton RN, Beale R, Smithies MN, Mason RC. Liver function and splanchnic ischemia in critically ill patients. Chest. 1997; 111: 180-7.
10. Dahn MS, Wilson RF, Lange MP, Stone A. Jacobs LA. Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg. 1990; 125: 441-3.
11. Dahn MS, Lange MP, Wilson RF, Jacobs LA, Mitchell RA. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery. 1990; 107: 295-301.
12. Smedsröd B, De Bleser PJ, Braet F, et al. Cell biology of liver endothelial and Kupffer cells. Gut. 1994; 35: 1509-16.
13. Boler RK, Bibighaus III AJ. Ultrastructural alterations of dog livers during endotoxic shock. Lab Invest. 1967; 17: 537-61.
14. Thiemermann C. The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol. 1994; 28: 45-78.
15. Szabó C, Mitchell JA, Thiemermann C. Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 1993; 108: 786-92.
16. Cobb JP, Danner RL. Nitric oxide and septic shock. JAMA. 1996; 275: 1192-6.
17. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol. 1990; 48: 565-9.
18. Harbrecht BG, Billiar TR, Stadler J, et al. Inhibition of nitric-oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol. 1992; 52: 390-4.
19. Pastor CM, Payen DM. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock. 1994; 2: 196-202.
20. Gundersen Y, Soetre T, Carlsen H, Scholz T, Lilleaasen P. Aasen AO. Modulators of nitric oxide in porcine endotoxemia: Effects on hepatic oxygen delivery and consumption. Eur Surg Res. 1997; 29: 237-45.
21. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 1992; 26: 48-57.
22. Pastor CM, Losser M-R, Payen D. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology. 1995; 22: 1547-53.
23. Gundersen Y, Corso CO, Leiderer R, et al. Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: Effects on hepatic morphology and function. Shock. 1997; 8: 368-72.
24. Bauer C, Walcher F, Kalweit U, Larsen R, Marzi I. Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. J Hepatol. 1997; 27: 1089-95.
25. Huang T-P, Nishida T, Kamiike W, et al. Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia. Hepatology. 1997; 26: 336-42.
26. Nishida J, McCuskey RS, McDonnell D, Fox ES. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol. 1994; 267: G1135-1141.
27. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990; 192: 245-61.
28. Curzen NP, Griffiths MJD, Evans TW. Role of the endothelium in modulating the vascular response to sepsis. Clin Sci. 1994; 86: 359-74.
29. Sayeed MM, Maitra SR. Effect of diltiazem on altered calcium regulation during endotoxic shock. Am J Physiol. 1987; 253: R549-54.
30. Spapen H, Zhang H, Vincent J-L, Thoné F, Borgers M. Intrahepatocellular erythrocyte inclusions and increased calcium precipitation in canine endotoxic shock. J Hepatol. 1997; 27: 1096-1105.
31. Pugin J, Schürer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lypopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90: 2744-8.
32. Molnar RG, Wang P, Ayala A, Ganey PE, Roth RA, Chaudry IH. The role of neutrophils in producing hepatocellular dysfunction during the hyperdynamic stage of sepsis in rats. J Surg Res. 1997; 73: 117-22.
33. Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: Adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 1996; 139: 213-26.
34. Ohira H, Ueno T, Torimura T, Tanikawa K, Kasukawa R. Leukocyte adhesion molecules in the liver and plasma cytokine levels in endotoxin-induced rat liver injury. Scand J Gastroenterol 1995; 30: 1027-35.
35. Chosay JG, Essani NA, Dunn CJ, Jaeschke H. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol. 1997; 272: G1195-1200.
36. Harbrecht BG, Billiar TR, Curran RD, Stadler J, Simmons RL. Hepatocyte injury by activated neutrophils in vitro is mediated by proteases. Ann Surg. 1993; 218: 120-8.
37. Asaka S, Shibayama Y, Nakata K. Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: Microscopic observation in vivo. Liver. 1996; 16: 183-7.
38. De Backer D, Zhang H, Manikis P, Vincent JL. Regional effects of dobutamine in endotoxic shock. J Surg Res. 1996; 65: 93-100.
39. Gutierrez G, Clark C, Brown SD, et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med. 1994; 150: 324-9.
40. Tighe D, Moss R, Heywood G, Al-Saady N, Webb A, Bennett D. Goal-directed therapy with dopexamine, dobutamine, and volume expansion: Effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. Crit Care Med. 1995; 23: 1997-2007.
41. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent J-L. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am J Physiol. 1994: 266: H1746-54.
42. Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H. Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances. Intensive Care Med. 1998; 24: 967-72.
43. Zhang H, Spapen H, Manikis P, et al. Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs. Am J Physiol. 1995; 268: H1847-55.
44. Schmidt H, Schmidt W, Müller T, et al. Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia. Surgery. 1997; 121: 328-34.
45. Spapen H, Zhang H, Wisse E, et al. The 21-aminosteroid U74389G enhances hepatic blood flow and protects the sinusoidal endothelium in acute canine endotoxic shock. J Surg Res. (submitted for publication).
46. Sha M, Saito Y, Yokoyama K, Sawa T, Amaka K. Effects of continuous positive pressure ventilation on hepatic blood flow and intrahepatic oxygen delivery in dogs. Crit Care Med. 1987; 15: 1040-3.
47. Heyland DK. Nutritional support in the critically ill patient. A critical review of the evidence. Crit Care Clin. 1998; 14: 423-40.
48. Wang P, Zheng FB, Chaudry IC. Nitric oxide. To block or enhance its production during sepsis? Arch Surg. 1994; 129: 1137-43.
49. Liaudet L, Schaller MD, Feihl F. Selective pharmacological inhibition of inducible nitric oxide synthase in experimental septic shock. In: Vincent J-L, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg: Springer-Verlag. 1998: 161-77.